HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.

AuthorsJ F de Fremont, J L Sebert, J Gueris, P Marie, B Coevoet, R Makdassi, G Lambrey, P Meunier, A Fournier
JournalProceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association (Proc Eur Dial Transplant Assoc) Vol. 16 Pg. 675-6 ( 1979) ISSN: 0071-2736 [Print] England
PMID232918 (Publication Type: Journal Article)
Chemical References
  • Parathyroid Hormone
  • Phosphates
  • Vitamin D
  • Cholecalciferol
  • Alkaline Phosphatase
Topics
  • Alkaline Phosphatase (blood)
  • Cholecalciferol (therapeutic use)
  • Humans
  • Osteitis Fibrosa Cystica (drug therapy)
  • Parathyroid Hormone (blood)
  • Phosphates (blood)
  • Renal Dialysis
  • Vitamin D (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: